Crosstalk of hedgehog and Wnt pathways in gastric cancer

Cancer Letters

Volumn 263, Issue 1, 2008, Pages 145-156

  Yanai, Kosuke ^a   Nakamura, Masafumi ^a   Akiyoshi, Takashi ^a   Nagai, Shuntaro ^a   Wada, Junji ^a   Koga, Kenichiro ^a   Noshiro, Hirokazu ^b   Nagai, Eishi ^a   Tsuneyoshi, Masazumi ^a   Tanaka, Masao ^a   Katano, Mitsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU KOSEI NENKIN HOSPITAL   (Japan)

Author keywords

catenin; Gastric cancer; Gli1; Hedgehog signaling; Wnt signaling

Indexed keywords

BETA CATENIN; LUCIFERASE; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1; WNT PROTEIN;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA METHYLATION; GENE VECTOR; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; STOMACH CANCER; STOMACH CARCINOGENESIS; WESTERN BLOTTING;

BASE SEQUENCE; DNA PRIMERS; HEDGEHOG PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; WNT PROTEINS;

ERINACEIDAE;

EID: 41049117410     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.12.030     Document Type: Article

References (49)

1. Ingham P.W., and McMahon A.P. Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 15 (2001) 3059-3087
2. Ruiz i Altaba A., Sanchez P., and Dahmane N. Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat. Rev. Cancer 2 (2002) 361-372
3. Ramalho-Santos M., Melton D.A., and McMahon A.P. Hedgehog signals regulate multiple aspects of gastrointestinal development. Development 127 (2000) 2763-2772
4. Pasca di Magliano M., and Hebrok M. Hedgehog signalling in cancer formation and maintenance. Nat. Rev. Cancer 3 (2003) 903-911
5. Lee J., Platt K.A., Censullo P., and Ruiz i Altaba A. Gli1 is a target of Sonic hedgehog that induces ventral neural tube development. Development 124 (1997) 2537-2552
6. Katoh Y., and Katoh M. Hedgehog signaling pathway and gastrointestinal stem cell signaling network (review). Int. J. Mol. Med. 18 (2006) 1019-1023
7. Karlstrom R.O., Tyurina O.V., Kawakami A., Nishioka N., Talbot W.S., Sasaki H., and Schier A.F. Genetic analysis of zebrafish gli1 and gli2 reveals divergent requirements for gli genes in vertebrate development. Development 130 (2003) 1549-1564
8. Kubo M., Nakamura M., Tasaki A., Yamanaka N., Nakashima H., Nomura M., Kuroki S., and Katano M. Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer. Cancer Res. 64 (2004) 6071-6074
9. Watkins D.N., Berman D.M., Burkholder S.G., Wang B., Beachy P.A., and Baylin S.B. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 422 (2003) 313-317
10. Thayer S.P., di Magliano M.P., Heiser P.W., Nielsen C.M., Roberts D.J., Lauwers G.Y., Qi Y.P., Gysin S., Fernandez-del Castillo C., Yajnik V., Antoniu B., McMahon M., Warshaw A.L., and Hebrok M. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425 (2003) 851-856
11. Berman D.M., Karhadkar S.S., Maitra A., Montes De Oca R., Gerstenblith M.R., Briggs K., Parker A.R., Shimada Y., Eshleman J.R., Watkins D.N., and Beachy P.A. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425 (2003) 846-851
12. Karhadkar S.S., Bova G.S., Abdallah N., Dhara S., Gardner D., Maitra A., Isaacs J.T., Berman D.M., and Beachy P.A. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 431 (2004) 707-712
13. Ma X., Chen K., Huang S., Zhang X., Adegboyega P.A., Evers B.M., Zhang H., and Xie J. Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas. Carcinogenesis 26 (2005) 1698-1705
14. Fukaya M., Isohata N., Ohta H., Aoyagi K., Ochiya T., Saeki N., Yanagihara K., Nakanishi Y., Taniguchi H., Sakamoto H., Shimoda T., Nimura Y., Yoshida T., and Sasaki H. Hedgehog signal activation in gastric pit cell and in diffuse-type gastric cancer. Gastroenterology 131 (2006) 14-29
15. Yanai K., Nagai S., Wada J., Yamanaka N., Nakamura M., Torata N., Noshiro H., Tsuneyoshi M., Tanaka M., and Katano M. Hedgehog signaling pathway is a possible therapeutic target for gastric cancer. J. Surg. Oncol. 95 (2007) 55-62
16. Logan C.Y., and Nusse R. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20 (2004) 781-810
17. Wodarz A., and Nusse R. Mechanisms of Wnt signaling in development. Annu. Rev. Cell Dev. Biol. 14 (1998) 59-88
18. Fodde R., Smits R., and Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat. Rev. Cancer 1 (2001) 55-67
19. Polakis P. Wnt signaling and cancer. Genes Dev. 14 (2000) 1837-1851
20. Korinek V., Barker N., Morin P.J., van Wichen D., de Weger R., Kinzler K.W., Vogelstein B., and Clevers H. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275 (1997) 1784-1787
21. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B., and Kinzler K.W. Identification of c-MYC as a target of the APC pathway. Science 281 (1998) 1509-1512
22. Tetsu O., and McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398 (1999) 422-426
23. Chamorro M.N., Schwartz D.R., Vonica A., Brivanlou A.H., Cho K.R., and Varmus H.E. FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development. EMBO J. 24 (2005) 73-84
24. Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., and Kinzler K.W. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275 (1997) 1787-1790
25. Liu W., Dong X., Mai M., Seelan R.S., Taniguchi K., Krishnadath K.K., Halling K.C., Cunningham J.M., Boardman L.A., Qian C., Christensen E., Schmidt S.S., Roche P.C., Smith D.I., and Thibodeau S.N. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat. Genet. 26 (2000) 146-147
26. Powell S.M., Zilz N., Beazer-Barclay Y., Bryan T.M., Hamilton S.R., Thibodeau S.N., Vogelstein B., and Kinzler K.W. APC mutations occur early during colorectal tumorigenesis. Nature 359 (1992) 235-237
27. Horii A., Nakatsuru S., Miyoshi Y., Ichii S., Nagase H., Kato Y., Yanagisawa A., and Nakamura Y. The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer. Cancer Res. 52 (1992) 3231-3233
28. Sasaki Y., Morimoto I., Kusano M., Hosokawa M., Itoh F., Yanagihara K., Imai K., and Tokino T. Mutational analysis of the beta-catenin gene in gastric carcinomas. Tumour Biol. 22 (2001) 123-130
29. Tong J.H., To K.F., Ng E.K., Lau J.Y., Lee T.L., Lo K.W., Leung W.K., Tang N.L., Chan F.K., Sung J.J., and Chung S.C. Somatic beta-catenin mutation in gastric carcinoma--an infrequent event that is not specific for microsatellite instability. Cancer Lett. 163 (2001) 125-130
30. Clements W.M., Wang J., Sarnaik A., Kim O.J., MacDonald J., Fenoglio-Preiser C., Groden J., and Lowy A.M. beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res. 62 (2002) 3503-3506
31. Yuasa Y. Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat. Rev. Cancer 3 (2003) 592-600
32. Tamura G. Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J. Gastroenterol. 12 (2006) 192-198
33. Miyazawa K., Iwaya K., Kuroda M., Harada M., Serizawa H., Koyanagi Y., Sato Y., Mizokami Y., Matsuoka T., and Mukai K. Nuclear accumulation of beta-catenin in intestinal-type gastric carcinoma: correlation with early tumor invasion. Virchows Arch. 437 (2000) 508-513
34. Grabsch H., Takeno S., Noguchi T., Hommel G., Gabbert H.E., and Mueller W. Different patterns of beta-catenin expression in gastric carcinomas: relationship with clinicopathological parameters and prognostic outcome. Histopathology 39 (2001) 141-149
35. Heemskerk J., and DiNardo S. Drosophila hedgehog acts as a morphogen in cellular patterning. Cell 76 (1994) 449-460
36. Silva-Vargas V., Lo Celso C., Giangreco A., Ofstad T., Prowse D.M., Braun K.M., and Watt F.M. Beta-catenin and Hedgehog signal strength can specify number and location of hair follicles in adult epidermis without recruitment of bulge stem cells. Dev. Cell 9 (2005) 121-131
37. Noramly S., Freeman A., and Morgan B.A. Beta-catenin signaling can initiate feather bud development. Development 126 (1999) 3509-3521
38. Iwatsuki K., Liu H.X., Gronder A., Singer M.A., Lane T.F., Grosschedl R., Mistretta C.M., and Margolskee R.F. Wnt signaling interacts with Shh to regulate taste papilla development. Proc. Natl. Acad. Sci. USA 104 (2007) 2253-2258
39. van den Brink G.R., Bleuming S.A., Hardwick J.C., Schepman B.L., Offerhaus G.J., Keller J.J., Nielsen C., Gaffield W., van Deventer S.J., Roberts D.J., and Peppelenbosch M.P. Indian Hedgehog is an antagonist of Wnt signaling in colonic epithelial cell differentiation. Nat. Genet. 36 (2004) 277-282
40. Akiyoshi T., Nakamura M., Koga K., Nakashima H., Yao T., Tsuneyoshi M., Tanaka M., and Katano M. Gli1, downregulated in colorectal cancers, inhibits proliferation of colon cancer cells involving Wnt signalling activation. Gut 55 (2006) 991-999
41. He J., Sheng T., Stelter A.A., Li C., Zhang X., Sinha M., Luxon B.A., and Xie J. Suppressing Wnt signaling by the hedgehog pathway through sFRP-1. J. Biol. Chem. 281 (2006) 35598-35602
42. Suzuki H., Watkins D.N., Jair K.W., Schuebel K.E., Markowitz S.D., Chen W.D., Pretlow T.P., Yang B., Akiyama Y., Van Engeland M., Toyota M., Tokino T., Hinoda Y., Imai K., Herman J.G., and Baylin S.B. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat. Genet. 36 (2004) 417-422
43. Nojima M., Suzuki H., Toyota M., Watanabe Y., Maruyama R., Sasaki S., Sasaki Y., Mita H., Nishikawa N., Yamaguchi K., Hirata K., Itoh F., Tokino T., Mori M., Imai K., and Shinomura Y. Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer. Oncogene (2007)
44. Sobin L.H., and Wittekind C. International Union Against Cancer (UICC). TNM Classification of Malignant Tumors. 5th ed. (1997), Wiley-Liss, New York
45. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma - 2nd English Edition. Gastric Cancer 1 (1998) 10-24
46. Sugano H., Nakamura K., and Kato Y. Pathological studies of human gastric cancer. Acta Pathol. Jpn. 32 Suppl 2 (1982) 329-347
47. Caca K., Kolligs F.T., Ji X., Hayes M., Qian J., Yahanda A., Rimm D.L., Costa J., and Fearon E.R. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer. Cell Growth Differ. 10 (1999) 369-376
48. Sasaki H., Hui C., Nakafuku M., and Kondoh H. A binding site for Gli proteins is essential for HNF-3beta floor plate enhancer activity in transgenics and can respond to Shh in vitro. Development 124 (1997) 1313-1322
49. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., and Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93 (1996) 9821-9826